Axon Enterprise, Inc. (NASDAQ:AXON) Stock Holdings Lessened by Teamwork Financial Advisors LLC

Teamwork Financial Advisors LLC cut its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 25.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 7,920 shares of the biotechnology company’s stock after selling 2,752 shares during the quarter. Teamwork Financial Advisors LLC’s holdings in Axon Enterprise were worth $4,707,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Insigneo Advisory Services LLC boosted its stake in Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock worth $627,000 after purchasing an additional 22 shares during the period. Menard Financial Group LLC grew its holdings in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after buying an additional 24 shares in the last quarter. PFG Investments LLC raised its position in Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after buying an additional 25 shares during the period. Gladstone Institutional Advisory LLC lifted its stake in Axon Enterprise by 1.6% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after acquiring an additional 26 shares in the last quarter. Finally, Mather Group LLC. boosted its position in Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock worth $303,000 after acquiring an additional 27 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the sale, the insider now directly owns 154,394 shares in the company, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. JMP Securities increased their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Needham & Company LLC boosted their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Robert W. Baird increased their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $504.92.

Axon Enterprise Stock Up 0.3 %

AXON opened at $607.60 on Thursday. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The business has a 50 day moving average price of $617.26 and a 200 day moving average price of $466.40. The firm has a market cap of $46.33 billion, a P/E ratio of 157.00, a price-to-earnings-growth ratio of 6.07 and a beta of 1.04.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.